1. Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT alone. Issue 7 (6th July 2020) Authors: Bradshaw, Daniel; Gilleece, Yvonne; Verma, Sumita; Abramowicz, Iga; Bremner, Stephen; Perry, Nicky Journal: BMJ open Issue: Volume 10:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗